Top news of the week: 04.08.2020.

#pharmaceuticals #COVID #biotechnology #vaccine #COVID19 #coronavirus #biospace #lifesciences #treatment #pandemic

Companies And Industries

On Jul 31, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: July 31 #biospace #lifesciences #biotechnology #pharmaceuticals #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine https://t.co/Zd8hx3RMCD
Open

Biopharma Update on the Novel Coronavirus: July 31

Biopharma Update on the Novel Coronavirus: July 31

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 31, 2020.

On Aug 3, 2020
@biospace shared
Biopharma Update on the Novel Coronavirus: August 3 #biospace #lifesciences #biotechnology #pharmaceuticals #COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine https://t.co/eZa4s4KMfo
Open

Biopharma Update on the Novel Coronavirus: August 3

Biopharma Update on the Novel Coronavirus: August 3

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 3, 2020.

On Jul 31, 2020
@BioWorld shared
Biopharma sector’s Q2 earning updates buffeted and braced by pandemic https://t.co/Y1lEUZzEgP
Open

Biopharma sector’s Q2 earning updates buffeted and braced by pandemic

Biopharma sector’s Q2 earning updates buffeted and braced by pandemic

Second-quarter earnings reports, flowing fast in the last days of July, delivered a bevy of contrasting results, from A to V. Stymied by the pandemic, Aimmune Therapeutics Inc. booked ...

On Aug 3, 2020
@BioWorld shared
Summertime blues for top-tier biopharmaceutical companies https://t.co/n2FeNizK8V
Open

Summertime blues for top-tier biopharmaceutical companies

Summertime blues for top-tier biopharmaceutical companies

The share prices of blue-chip biopharmaceutical companies continued on their lackluster trajectory, which started in June and collectively lost ground last month, with the BioWorld ...

On Jul 30, 2020
@BiotechWorld shared
F-star set to land Nasdaq listing through Spring Bank merger https://t.co/UQMcNBbJti https://t.co/n9pHGLhW8g
Open

F-star set to land Nasdaq listing through Spring Bank merger

F-star set to land Nasdaq listing through Spring Bank merger

F-star Therapeutics is set to merge with Spring Bank Pharmaceuticals, giving it a Nasdaq listing to support the advance of its pipeline of bispecific antibodies. The merger comes months ...

On Jul 30, 2020
@KBIBiopharma shared
Faster time to clinic means faster time to market. With Gene-to-GMP, we're accelerating the development of innovative discoveries into life-changing biological medicines - faster than ever. Learn more: https://t.co/0wqV6mkjDf https://t.co/J8Mynjm0iu
Open

Your CDMO partner of the 21st Century

Your CDMO partner of the 21st Century

KBI Biopharma Inc. is a global Contract development and manufacturing organization (CDMO / CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical & ...

On Jul 29, 2020
@FierceBiotech shared
Rather than switching genes on and off, cutting out disease-causing genes or replacing them with healthy versions, Omega’s platform is designed to adjust gene expression to healthy levels https://t.co/7A0kTRqRGu
Open

'Genome-tuning' biotech Omega Therapeutics snags $85M as it aims for the clinic

'Genome-tuning' biotech Omega Therapeutics snags $85M as it aims for the clinic

Omega Therapeutics' $85 million cash boost will push a pipeline of treatments toward the clinic as well as bankroll the identification of new targets for genomic medicines. Rather than ...

On Aug 3, 2020
@BIRAC_2012 shared
RT @BRTC_KIIT_TBI: Envision to Create an Impact? Calling #researchers #startups #innovators & aspiring #entrepreneurs to take your #idea/#innovation to the next level with @BIRAC_2012 BIG and KIIT-TBI. Apply for 50 Lakhs Grant-in-aid now! Ask for LoI: https://t.co/HmcNCV3O6L Apply B4 September 15 https://t.co/UptmxdbGPe
Open

KIIT-TBI: LoI Issue for BIG 17th Call

KIIT-TBI: LoI Issue for BIG 17th Call

Biotechnology Ignition Grant Through BIG funding, a grant of up to 50 Lakhs for 18 months is provided to biotech startups and entrepreneurial individuals to propel best in class innovative ...